Implication of ACE Trial results / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism
; (12): 93-95, 2018.
Article
de Zh
| WPRIM
| ID: wpr-709912
Bibliothèque responsable:
WPRO
ABSTRACT
Pre-diabetes is at increased risk of development of type 2 diabetes and future cardiovascular events. Preventing the progression of pre-diabetic populations to diabetes is important. The Acarbose Cardiovascular Evaluation(ACE) trial was the largest pre-diabetes intervention study conducted in China. The study found that acarbose treatment can significantly reduce the risk of new-onset diabetes in IGT patients with CVD on the basis of life interventions,but the cardiovascular benefits for the population are not significant. ACE study showed that acarbose can prevent the conversion of IGT to diabetes,which plays a key role in the prevention of diabetes.
Texte intégral:
1
Indice:
WPRIM
langue:
Zh
Texte intégral:
Chinese Journal of Endocrinology and Metabolism
Année:
2018
Type:
Article